iRhythm Technologies Inc Total Liabilities

Latest as of March 2026: $845.15 Million USD

iRhythm Technologies Inc total liabilities. Based on the latest financial reports, iRhythm Technologies Inc (IRTC) has total liabilities worth $845.15 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check iRhythm Technologies Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of iRhythm Technologies Inc (2013–2025)

Total liabilities of iRhythm Technologies Inc from 2013 to 2025. This chart illustrates how iRhythm Technologies Inc's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of iRhythm Technologies Inc to see how much of total assets are deployed in long-term investments.

iRhythm Technologies Inc Competitors by Total Liabilities

The table below lists competitors of iRhythm Technologies Inc ranked by their total liabilities.

Company Country Total Liabilities
WSFS Financial Corporation
NASDAQ:WSFS
USA $18.59 Billion
Stepstone Group Inc
NASDAQ:STEP
USA $6.53 Billion
Thunder Software Technology Co Ltd
SHE:300496
China CN¥2.78 Billion
G-bits Network Technology Xiamen Co Ltd
SHG:603444
China CN¥2.09 Billion
Corporación Inmobiliaria Vesta S.A.B. de C.V
MX:VESTA
Mexico MX$1.69 Billion
Andon Health Co Ltd
SHE:002432
China CN¥8.08 Billion
Guangdong HongDa Blasting Co Ltd
SHE:002683
China CN¥16.94 Billion
Kesko Oyj
HE:KESKOA
Finland €6.89 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down iRhythm Technologies Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is iRhythm Technologies Inc's balance sheet.

Liquidity & Leverage Metrics

iRhythm Technologies Inc Total Liabilities Ratios Explained

iRhythm Technologies Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 5.17 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 5.24 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.84 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how iRhythm Technologies Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for iRhythm Technologies Inc (2013–2025)

The table below shows the annual total liabilities of iRhythm Technologies Inc from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 $867.30 Million +3.18%
2024-12-31 $840.54 Million +276.84%
2023-12-31 $223.05 Million +7.02%
2022-12-31 $208.41 Million +13.60%
2021-12-31 $183.45 Million +7.83%
2020-12-31 $170.13 Million -0.40%
2019-12-31 $170.80 Million +161.61%
2018-12-31 $65.29 Million +21.87%
2017-12-31 $53.57 Million +17.49%
2016-12-31 $45.59 Million -67.32%
2015-12-31 $139.50 Million +1140.52%
2014-12-31 $11.24 Million +29.80%
2013-12-31 $8.66 Million --

About iRhythm Technologies Inc

NASDAQ:IRTC USA Medical Devices
Market Cap
$4.15 Billion
Market Cap Rank
#4222 Global
#1497 in USA
Share Price
$126.37
Change (1 day)
+0.16%
52-Week Range
$101.79 - $189.25
All Time High
$268.46
About

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring s… Read more